tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RNAC Stock Latest News

Cartesian Therapeutics announces FDA SPA agreement for Phase 3 AURORA trial
The FlyCartesian Therapeutics announces FDA SPA agreement for Phase 3 AURORA trial
4d ago
RNAC
Cartesian Therapeutics Sets 2025 Strategy for Descartes-08
PremiumCompany Announcements
Cartesian Therapeutics Sets 2025 Strategy for Descartes-08
18d ago
8K
RNAC
Cartesian Therapeutics highlights progress, 2025 strategic priorities
PremiumThe Fly
Cartesian Therapeutics highlights progress, 2025 strategic priorities
18d ago
RNAC
Cartesian Therapeutics announces employment inducement grants
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grants
24d ago
RNAC
Cartesian Therapeutics initiated with a Buy at BTIG
PremiumThe Fly
Cartesian Therapeutics initiated with a Buy at BTIG
1M ago
RNAC
Cartesian Therapeutics announces employment inducement grants
PremiumThe FlyCartesian Therapeutics announces employment inducement grants
1M ago
RNAC
Cartesian Therapeutics files to sell 11.39M shares of common stock for holders
Premium
The Fly
Cartesian Therapeutics files to sell 11.39M shares of common stock for holders
2M ago
RNAC
Cartesian Therapeutics files to sell 6.25M shares of common stock for holders
Premium
The Fly
Cartesian Therapeutics files to sell 6.25M shares of common stock for holders
2M ago
RNAC
Cartesian Therapeutics files $400M mixed securities shelf
PremiumThe Fly
Cartesian Therapeutics files $400M mixed securities shelf
2M ago
RNAC
Cartesian Therapeutics price target raised to $45 from $41 at H.C. Wainwright
PremiumThe Fly
Cartesian Therapeutics price target raised to $45 from $41 at H.C. Wainwright
2M ago
RNAC
Cartesian Therapeutics Reports Promising Phase 2b Trial Results
PremiumCompany Announcements
Cartesian Therapeutics Reports Promising Phase 2b Trial Results
2M ago
8K
RNAC
Cartesian Therapeutics reports positive updated Phase 2b results in myasthenia
PremiumThe Fly
Cartesian Therapeutics reports positive updated Phase 2b results in myasthenia
2M ago
RNAC
Needham biotech analyst holds an analyst/industry conference call
PremiumThe FlyNeedham biotech analyst holds an analyst/industry conference call
2M ago
RNAC
Cartesian to present updated data from Phase 2b trial of Descartes-08
Premium
The Fly
Cartesian to present updated data from Phase 2b trial of Descartes-08
2M ago
RNAC
Cartesian Therapeutics Reports Q3 2024 Financial Results
Premium
Company Announcements
Cartesian Therapeutics Reports Q3 2024 Financial Results
3M ago
RNAC
Cartesian Therapeutics announces employment inducement grant
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grant
3M ago
RNAC
Cartesian Therapeutics price target lowered to $41 from $45 at H.C. Wainwright
PremiumThe Fly
Cartesian Therapeutics price target lowered to $41 from $45 at H.C. Wainwright
3M ago
RNAC
Cartesian Therapeutics reports Q3 EPS ($1.13) , consensus (79c)
PremiumThe Fly
Cartesian Therapeutics reports Q3 EPS ($1.13) , consensus (79c)
3M ago
RNAC
Cartesian announces Phase 2b trial of Descartes-08 achieved primary endpoint
PremiumThe Fly
Cartesian announces Phase 2b trial of Descartes-08 achieved primary endpoint
4M ago
RNAC
Cartesian Therapeutics announces employment inducement grant
PremiumThe FlyCartesian Therapeutics announces employment inducement grant
4M ago
RNAC
Three new option listings and eighteen option delistings on September 23rd
Premium
The Fly
Three new option listings and eighteen option delistings on September 23rd
4M ago
BFI
TPL
Cartesian receives FDA Rare Pediatric Disease Designation for Descartes-08
Premium
The Fly
Cartesian receives FDA Rare Pediatric Disease Designation for Descartes-08
5M ago
RNAC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >